Rising Biosciences Inc. (RBII)

Overview

Rising BioSciences, Inc. is a company dedicated to the development and manufacture of innovative topical and oral pharmaceutical products, placing a strong emphasis on the integration of medical marijuana into their product line. Situated in Sheridan, Wyoming, the company is positioned in the burgeoning field of pharmaceuticals that incorporate cannabis-derived components for therapeutic purposes. Rising BioSciences focuses on harnessing the potential medical benefits of marijuana, aligning with the growing acceptance and legalization of cannabis for medical use across various regions.

Products and Services

• Topical Pharmaceutical Products

  Rising BioSciences, Inc. specializes in the creation of topical products, which are designed for direct application to the skin. These products are developed to address a variety of conditions, offering pain relief and anti-inflammatory properties among other therapeutic benefits. By incorporating medical marijuana extracts, these topical solutions leverage the analgesic and healing effects of cannabinoids, making them suitable for treating conditions such as arthritis, muscle soreness, and skin ailments.

• Oral Pharmaceutical Products

  The company also focuses on the development of oral pharmaceutical products, which include capsules, tablets, and liquid formulations that contain medical marijuana. These products are designed for patients who prefer or require internal medication for their conditions. The oral route provides a systemic effect, benefiting patients who need consistent relief from chronic conditions such as neuropathic pain, multiple sclerosis, and certain symptoms associated with cancer treatment. By carefully formulating these products, Rising BioSciences aims to offer alternatives that have predictable dosing, controlled delivery, and minimized psychoactive effects.

• Medical Marijuana Products

  In addition to traditional pharmaceutical products, Rising BioSciences is actively involved in the development and manufacture of specialized medical marijuana products. This includes a range of products specifically formulated to harness the medicinal properties of cannabis, addressing a wide range of conditions from chronic pain to anxiety and epilepsy. The company's involvement in this sector is indicative of its commitment to exploring innovative therapeutic avenues, ensuring access to alternative treatments that are both effective and compliant with regulatory standards.